| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $7.7M | +699.7% |
| SG&A Expense | $12.0M | -62.3% |
| Operating Income | -$21.6M | +36.0% |
| Net Income | -$21.3M | +36.4% |
| EPS (Basic) | -$0.49 | -880.0% |
| EPS (Diluted) | -$0.49 | +38.8% |
| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.3M | -92.0% |
| Inventory | $125K | — |
| Current Assets | $4.8M | -84.1% |
| Total Assets | $74.7M | +41.2% |
| Current Liabilities | $13.4M | +338.7% |
| Total Liabilities | $13.4M | +316.5% |
| Stockholders' Equity | $61.2M | +23.3% |
| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.4M | -31.3% |
| Capital Expenditures | $6.8M | -47.5% |
| Investing Cash Flow | -$36.7M | -143.4% |
| Financing Cash Flow | $23.4M | -43.4% |
| Free Cash Flow | -$20.1M | +12.7% |